已收盘 01-30 16:00:00 美东时间
+0.030
+0.24%
BRIEF-Americold Announces CFO Transition Jan 26 (Reuters) - Americold Realty Trust Inc COLD.N : AMERICOLD ANNOUNCES CFO TRANSITION AND EXPANDED LEADERSHIP ROLES TO SUPPORT COMPANY’S GROWTH PLAN AMERICOLD REALTY TRUST INC - CHRIS PAPA APPOINTED CFO EFFECTIVE FEBRUARY 23, 2026 AMERICOLD REALTY TRUST I
01-27 05:56
Americold Realty Trust (COLD) on Monday said that it appointed Christopher Papa as Executive Vice President and CFO, effective February 23, 2026. Papa most recently served as CFO of CenterPoint Proper...
01-27 05:30
Americold Realty Trust will release 2025 fourth-quarter and full-year financial results on February 19, 2026, before the market opens, followed by a conference call at 8:00 a.m. ET. A webcast will be available on www.americold.com, requiring registration 15 minutes prior. Participants can join via phone: domestic 1-877-407-3982 or international 1-201-493-6780. A replay will be available until March 5, 2026, with passcode 13758077. Americold, a gl...
01-21 12:00
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
UBS analyst Michael Goldsmith maintains Americold Realty Trust (NYSE:COLD) with a Neutral and raises the price target from $12 to $13.
01-09 00:13
As widely expected, returns across real estate subsectors varied significantly in 2025. While the S&P 500 real estate sector ended the year in red against the broader S&P 500’s ~16% gain, health care ...
01-04 01:26
Americold与On the Run合作,为澳Petrol & Convenience市场提供供应链解决方案,支持其全国扩张。 Americold凭借在高周转、高服务供应链领域的丰富经验,助力OTR实现快速扩张。该合作彰显了Oceania地区在冷链创新中的潜力,同时支持 Americold向新领域扩展,以实现增长目标。
2025-12-23 14:00
今日重点评级关注:Ascendiant Capital:维持SurgePays Inc"买入"评级,目标价从9.5美元升至9.75美元;Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从8美元升至10美元
2025-12-23 12:32